AFYX Therapeutics Presents New Study Showing Therapeutic Antibody Delivery
07 Sep 2021 //
BUSINESSWIRE
Qlaris Bio Enrolls First Patient in Phase 1/2 of invg Glaucoma Drug QLS-101
15 Apr 2021 //
EYEWIRE
AFYX Presents Phase 2 Data of Rivelin-CLO at 2021 AAOM Virtual Conference
15 Apr 2021 //
BUSINESSWIRE